Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;53(5):480-7.
doi: 10.1093/cid/cir434.

Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort

Affiliations

Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort

Ann M Dennis et al. Clin Infect Dis. 2011 Sep.

Abstract

Background: Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite advances in therapy and prognosis. The southeastern United States is a rapidly growing Latino settlement area where ethnic disparities may contribute to late presentation to care.

Methods: We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care initiation in the University of North Carolina Center for AIDS Research Clinical Cohort. We identified independent predictors of late presentation, defined as a CD4(+) T lymphocyte (CD4) count <350 cells/mm(3) or an AIDS-defining event (ADE), using log-linear binomial regression.

Results: During the period 1999-2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were white, and 61% were black. Median initial CD4 counts were lower for Latino patients (186 cells/mm(3)) than white patients (292 cells/mm(3); P = .006) and black patients (302 cells/mm(3); P = .02). Latino persons were more likely to be late presenters than white or black persons (76% vs 58%; P < .001) and accounted for 86%, 75%, and 50% of all presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively. Latino ethnicity, older age, male sex, and earlier entry year were independently associated with late presentation (P < .05 for all). In multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons (95% confidence interval, 1.15-1.45).

Conclusions: Latinos are more likely to initiate HIV care later in the course of illness than are black and white persons and account for a majority of several ADEs. Strategies to improve earlier HIV testing among Latinos in new settlement areas are needed.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of patients by race/ethnicity presenting with CD4+ cell counts <350 cells/mm3 by time period entering care. Categorized by CD4+ cell count distribution.
Figure 2.
Figure 2.
AIDS-defining events diagnosed at presentation to care by race/ethnicity. Figure represents total number of cases and overall prevalence (%) within each race/ethnicity. *Other conditions include coccidioidomycosis (n = 1), chronic cryptosporidiosis (n = 3), chronic herpes simplex ulcers (n = 1), recurrent pneumonia (n = 1), progressive multifocal leukoencephalopathy (n = 3), and recurrent Salmonella septicemia (n = 1).

Comment in

References

    1. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119. - PubMed
    1. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568–77. - PubMed
    1. Centers for Disease Control and Prevention. Late HIV testing—34 states, 1996–2005. MMWR Morb Mortal Wkly Rep. 2009;58:661–5. - PubMed
    1. Althoff KN, Gange SJ, Klein MB, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50:1512–20. - PMC - PubMed
    1. Espinoza L, Hall HI, Selik R, Hu X. Characteristics of HIV infection among Hispanics, United States 2003–2006. J Acquir Immune Defic Syndr. 2008;49:94–101. - PubMed

Publication types

MeSH terms

Substances